Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice by Chuize Kong et al.
RESEARCH ARTICLE Open Access
Overexpression of UNC5B in bladder cancer
cells inhibits proliferation and reduces the
volume of transplantation tumors in nude
mice
Chuize Kong1*, Bo Zhan1, Chiyuan Piao1, Zhe Zhang1, Yuyan Zhu1 and Qingchang Li2
Abstract
Background: The netrin-1 receptor UNC5B plays vital roles in angiogenesis, inflammation, embryonic development
and carcinogenesis. However, the functional significance of UNC5B overexpression in bladder cancer remains
unclear. In this study, we investigated the role of UNC5B in bladder cancer in vitro and in vivo.
Methods: Stable transfection of the human bladder cancer cell line 5637 with UNC5B (5637-U) was confirmed by
real-time RT-PCR, western blot and immunofluorescence assays. UNC5B expression in 5637 and 5637-U cells and
mice tumor specimens derived from these cell lines was analyzed by immunohistochemistryand western blotting.
Changes in the levels of cell cycle proteins were evaluated by western blotting. Flow cytometry, CCK-8 and scratch
tests were used to examine cell cycle distribution, proliferation and migration, respectively.
Results: UNC5B overexpression in 5637 cells inhibited cell multiplication and migration and induced cell cycle
arrest at the G2/M phase, meanwhile exhibited changes in the expression of cell cycle-associated proteins, showing
that UNC5B may inhibit metastatic behaviors in bladder cancer cells. In addition, tumors generated from 5637-U
cells were smaller than tumors generated from control 5637 cells.
Conclusions: Our findings suggest that UNC5B is a potential anti-neoplastic target in bladder cancer progression.
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Background
Bladder cancer is the commonest malignant tumor in
men worldwide and is associated with poor prognosis.
Despite recent improvements in bladder cancer therap-
ies, mortality rates have remained constant [1]. The
therapeutic potential of axon guidance factors and their
corresponding receptors in cancer therapy has recently
emerged. Among the three recently identified members
of the netrin family of axon guidance factors, netrin-1,
netrin-3 and netrin-4 [2–5], netrin-1 has received the
most attention. Netrin-1 is a 60–80 kD laminin-like
protein implicated in promoting cell invasion and
angiogenesis and inhibiting apoptosis in glioblastoma,
lung cancer and breast cancer [6–8]. Receptors of
netrin-1 include DCC, the UNC5H family of proteins
(UNC5A, UNC5B, UNC5C, and UNC5D) and neogenin
[9]. In-depth studies of UNC5B in tumors have revealed
that UNC5B is down-regulated in bladder cancer tissues
and that lower UNC5B expression is an independent
determinants for recurrence of bladder cancer [10].
These findings suggest that UNC5B may function as a
tumor suppressor in bladder cancer. In 2007, Bruno
Larrivée et al. demonstrated that UNC5B is down-
regulated in the existing vasculature of adults but is
re-expressed during angiogenesis and tumorigenesis,
indicating that UNC5B is a potential anti-angiogenic
therapeutic target [11]. Up-regulated expression of
netrin-1 and UNC5B has been observed in breast cancer
patients with distant metastasis [8]. In this study, we
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evaluated the effect of UNC5B overexpression on cell
proliferation and migration and the effect of UNC5B in
tumors implanted in nude mice. We observed a signifi-
cant decrease in proliferative and migratory activities
after UNC5B transfection, and the size of masses under
limbs was reduced in nude mice injected with UNC5B-
expressing cells.
Methods
Cells, plasmid and transfection procedures
The grade II human urinary bladder cancer cell line 5637
was selected for the UNC5B transfection and nude mouse
tumor transplantation experiment because 5637 is a suit-
able transfection host and has tumorigenic ability. The
cells were maintained in RPMI-1640 (Lonza, Verviers,
Belgium) supplemented with 10 % fetal bovine serum
(FBS) (EuroClone, West York, United Kingdom) at 37 °C
in a 5 % CO2 humidified incubator. The human recombin-
ant pcDNA-UNC5B-green fluorescent protein (GFP)
construct was purchased from GenePharma (Shanghai,
GenePharma Co., Ltd). 5637 cells stably expressing
pcDNA-UNC5B-GFP (hereafter referred to as 5637-U
cells) overexpressed UNC5B. For transfection, 2.5 μg of
pcDNA-UNC5B-GFP and 12 μl of Lipofectamine™ 2000
(Invitrogen, Carlsbad, CA) were added to 2 ml of serum-
free transfection medium and incubated for 24 h. The
transfected 5637 cells were cultured in medium supple-
mented with G418 (500 μg/ml) (Invitrogen) to select cells
stably transfected with pcDNA-UNC5B-GFP for approxi-
mately 14 days. Next, the 5637-U cells were cultured in
RPMI-1640 medium supplemented with 10 % FBS
containing G418 (500 μg/ml). Positive clones were deter-
mined by GFP immunofluorescence using a fluorescence
microscope (Olympus, Tokyo, Japan). Non-transfected
cells were used as controls.
Real-time RT-PCR analysis
TRIZOL reagent (Invitrogen, Carlsbad, CA) was used
for RNA extraction according to the manufacturer’s in-
structions, and the RNA was quantified using a Thermo
Scientific NanoDrop ND-100 (Wilmington, DE, USA).
PCR reactions were conducted in a Roche quantitative
PCR machine LC480 in a total reaction volume of 20 μl
with SYBR Green PCR Master Mix (Takara, Kyoto,
Japan). The PCR conditions were as follows: 50 °C for
2 min, 95 °C for 5 min, and 45 cycles of 95 °C for 40 s
and 55 °C for 30 s. The primer sequences were as
follows: β-actin sense: 5′-CTCCATCCTGGCCTCGCTG
T-3′; β-actin anti-sense: 5′-GCTGTCACCTTCACCGT
TCC-3′; UNC5B sense: 5′-CAGGGCAAGTTCTACGA-
GAT-3′; and UNC5B anti-sense: 5′-TGGTCCAGCAG-
GATGTGA-3′. The fold-change in UNC5B expression
was normalized to β-actin and calculated using the ΔΔCT
method. Experiments were performed in triplicate.
Western blot analysis
Cells were washed with pre-cooled PBS 3 times, lysed in
radioimmunoprecipitation assay (RIPA) buffer supple-
mented with phenylmethanesulfonyl fluoride protease
inhibitor cocktail and centrifuged at 12,000 rpm for
30 min. Total proteins in the supernatant were collected.
The protein concentration was determined using the BCA
assay (Beyotime, Shanghai, China), and the values were
normalized using a standard BSA curve. Then, 60 μg of
standardized protein per lane was separated by electro-
phoresis in an SDS-PAGE gel and transferred onto polyvi-
nylidene fluoride (PVDF) membranes. The membranes
were incubated at 4 °C overnight with primary antibodies
against UNC5B (1:1000) (Sigma, USA), GAPDH (1:2000)
(Sigma, USA), cyclin B1 (1:1000) (Abcam, Hong Kong),
cyclin D1 (1:1000) (Abcam, Hong Kong) and cyclin E
(1:1000) (Abcam, Hong Kong). The membranes were
subsequently incubated with secondary IgG antibody
(Santa Cruz Biotechnology) at 37 °C for 1 h with shaking,
and the bound proteins were visualized using the EC3 Im-
aging System (UVP Inc., Cambridge, UK).
Immunofluorescence technique
Immunofluorescence analyses were conducted using
5637 and 5637-U cell lines cultured in 24-well plates.
After the cells fusion, they were washed with PBS,
permeabilized with 0.3 % Triton X-100 for 1 h, and
30 min at 37 °C of 5 % BSA. Then cells were incubated
with UNC5B antibody (rabbit anti-human (1:1000))
overnight at 4 °C. After washing, the cells were incu-
bated with TRITC-conjugated (labeled goat anti-rabbit
IgG (1:200) secondary antibodies at 37 °C for 1 h in a
dark place. Nuclear was stained with DAPI. Immuno-
fluorescence images were observed utilizing an Inverted
Flurescence Microscopy (Olympus, Tokyo, Japan).
Cell cycle analysis
We cultured 5637 and 5637-U cells in serum-free
medium for 12 h and subsequently cultured them in
RPMI-1640 with 5 % FBS for an additional 24 h. Next,
the cells were harvested, washed once with PBS, slowly
combined with 75 % ice-cold ethanol and incubated
overnight at 4 °C. The cells were then centrifuged at
1200 g, resuspended in PI/RNase Staining Buffer (Becton
Dickinson Biosciences, San Jose, CA) and incubated for
30 min at 4 °C. The data of flow cytometry were ana-
lyzed using CellQuest Pro and ModFit software (Becton
Dickinson Biosciences, San Jose, CA).
Cell proliferation and wound healing assays
We used the Cell Counting Kit-8 (Beyotime, Shanghai,
China) assay to compare the growth of 5637 and 5637-U
cells. The two cell lines were plated at a density of 4.0 ×
103 cells per well in 96-well plates, and OD values were
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measured on each one of the 7 days. The experiments
were performed according to the manufacturer’s protocol.
5637 and 5637-U cells were plated at a density of 1 × 105
cells/well in 24-well plates and incubated in RPMI-1640
containing 10 % FBS for 24 h until they reached conflu-
ence. A wound was created in the adherent cells using a
200-μl pipette tip, followed by incubation with serum-free
RPMI-1640 medium for 24 h. The changes in wound area
were analyzed using an inverted microscope.
In vivo mouse models of bladder cancer
Animal experiments were formally approved by the
China Medical University Ethics Committee. Four-week-
old female SPF/VAF nude mice weighing approximately
13 g were purchased from Vitalriver China. Stably trans-
fected cells (5637-U) or normal cells (5637) (1 × 105cells
in 170 μl of RPMI1640 with 10 % FBS) were injected
into the armpit or rear flank of nude mice to form
implanted tumors. Tumor growth was monitored ap-
proximately every 2 days. At 47 days after injection, the
mice were sacrificed, and the specimens (tumor or liver)
were harvested for measurements and immunohisto-
chemical analysis. The resected specimens were rinsed
with PBS and fixed with 4 % formalin overnight.
Immunohistochemistry staining
Fresh tissues harvested from mice were fixed with 4 %
formalin for a minimum of 24 h. Next, the tissues were
Fig. 1 Transfection efficiency and expression of UNC5B in 5637 and 5637-U cells. a Detection of pcDNA-UNC5B-GFP in 5637-U cells using
immunofluorescence 3 and 30 days after transfection. b Quantification of UNC5B expression levels in 5637 and 5637-U cells by real-time RT-PCR.
c Evaluation of the stable transfection of 5637 cells with pcDNA-UNC5B-GFP by western blotting. Lane 1 represents untransfected 5637 cells, and
lane 2 represents cells 2 weeks after transfection with pcDNA-UNC5B-GFP
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embedded in paraffin, sectioned and transferred to glass
slides. Whole-mount immunostaining assays were con-
ducted by incubating the slides with antibodies against
UNC5B (1:200) (Sigma, USA), followed by secondary
antibodies. The samples were then stained with DAB
and rinsed. Nucleus were stained with hematoxylin
(Beyotime, Shanghai, China) for 5 min and rinsed with
water for more than 3 h. Images were captured using an
Upright Metallurgical Microscope (Olympus, Tokyo,
Japan).
Statistical methods
We used the software SPSS for Windows 17.0 (SPSS
Inc., Chicago, USA) for statistical analyses. Student’s
t-test was used to analyze differences in UNC5B expres-
sion, cell migration and cell cycle arrest between 5637
and 5637-U cells. Analysis of variance of repeated
measures was used to evaluate the growth curves of
5637 and 5637-U cells. P values <0.05 were considered
statistically significant.
Results
Identification of stable clones
As shown in Fig. 1a, the transfection efficiency of
pcDNA-UNC5B-GFP in 5637 cells was investigated by
fluorescence microscopy 7 days and 30 days after trans-
fection and then selection with 500 μg/ml G418. After
30 days, a substantial number of 5637 cells exhibited
green fluorescence, confirming stable transfection. The
expression of UNC5B in 5637-U cells and control 5637
cells was evaluated by real-time RT-PCR and western
blot assays. As shown in Fig. 1b, real-time PCR indicated
that UNC5B expression was increased 12-fold in 5637-U
cells compared with 5637 control cells (P = 0.037), and
western blot analysis using GAPDH as a loading control
revealed that UNC5B protein levels substantially
increased in 5637-U cells compared with 5637 cells
(Fig. 1c).
UNC5B Overexpression decreases cell proliferation and
migration
For the CCK-8 experiment, we inoculated relatively few
cells onto a 96-well plate and continuously observed the
cells for 7 days. On all 7 days, the proliferation of
5637-U cells was reduced compared with 5637 cells
(Fig. 2a). Significant differences were observed between
days (P < 0.001), and the difference in the growth rate of
5637 and 5637-U cells was also significant (P < 0.001).
Wound healing assays revealed significantly lower
migration of 5637-U cells compared with 5637 cells
(P < 0.05) (Fig. 2b).
Location of UNC5B in 5637-U aggregates to cytoplasm
Immunofluorescence results indicated that UNC5B was
mainly expressed in cytoplasm and a small number
located in nuclear. After stably overexpressed UNC5B,
more fluorescent spots aggregated in cytoplasm (Fig. 3).
Overexpression of UNC5B Induces G2/M arrest in 5637-U
cells
Flow cytometry analysis indicated that cell cycle prog-
ression was significantly inhibited in 5637-U cells com-
pared with 5637 cells (5637 cells: S phase 52.01 %; G2/
M phase 5.2 %; G0/G1 phase 42.76 %. 5637-U cells: S
phase 49.54 %; G2/M phase 15.34 %; G0/G1 phase
35.12 %) (P = 0.003) (Fig. 4). These data indicate that
UNC5B overexpression inhibited proliferation and
migration by inhibiting cell cycle progression at G2/M
phase.
The growth of tumors derived from 5637-U cells is
reduced compared with 5637 cells
Nude mice were injected with 5637 or 5637-U cells. The
two cell lines resulted in the formation of tumors of
different sizes on the back of mice and lethality at
Fig. 2 The proliferation and migration of 5637 cells is inhibited by
UNC5B overexpression. a Evaluation of the proliferation of 5637 and
5637-U cells by the CCK-8 assay. The OD values of 5637 cells were higher
than those of 5637-U cells on each of the 7 days examined. b Wound
healing assays were used to examine cell migration in 5637 and 5637-U
cells. Overexpression of UNC5B inhibited the migration of 5637 cells
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32 days to 47 days after injection. UNC5D overexpres-
sion has been suggested to inhibit cell multiplication,
migration and invasion in renal cancer cells by inducing
cell cycle arrest at G2/M phase [12]. These data indi-
cated that UNC5D may act as a tumor suppressor and
are consistent with our findings in bladder cancer cells.
We observed that tumors derived from 5637-U cells
grew at a slower rate and were smaller than tumors
derived from 5637 cells (P = 0.004) (Fig. 5a and b), impli-
cating UNC5B as a candidate tumor suppressor in blad-
der cancer. Representative images of 12 nude mice, 5
injected with 5637-U cells and 7 mice injected with 5637
cells, are shown in Fig. 5c. In general, tumor formation
requires the activation or inactivation of multiple signa-
ling pathways, and in some cases, multiple inputs from
related signaling pathways are required to induce tumor
formation.
Expression of cell cycle-associated proteins in 5637 and
5637-U cells
The expression of UNC5B and cell cycle proteinsin 5637
and 5637-U was evaluated by western blot analysis. The
expression of cyclin D1 was enhanced in 5637-U cells
compared with 5637 cells, whereas cyclin B1 and cyclin
E levels were unaffected (Fig. 1c).
Expression of UNC5B in 5637 and 5637-U-derived tumors
Tumors and livers from the sacrificed mice were
subjected to H&E and immunohistochemical analysis to
Fig. 4 Flow cytometry analysis of cell cycle progression in 5637 and
5637-U cells. There was a significant increase in the number of 5637-U
cells in G2/M phase compared with 5637 cells (15.34 % of 5637-U cells
and 5.2 % of 5637 cells, P = 0.003)
Fig. 3 Location of UNC5B in 5637 and 5637-U cells assessed by immunofluorescence analyses. UNC5B (green fluorescence) was mainly expressed in
cytoplasm while only a fraction located in nuclear. After UNC5B overexpressed, more green fluorescent spots assembled in cytoplasm as the yellow
arrows showed
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determine the level of UNC5B expression (Fig. 6a).
UNC5B protein expression was localized to both the
cytoplasm and the nuclear membranes in the tumor tis-
sues (Fig. 6b). Two of the mice injected with 5637 cells
appeared moribund at 19 and 32 days, and dissection
after sacrifice revealed hepatic metastasis (Fig. 6c).
Discussion
Axon guidance factors and their cognate receptors func-
tion in processes beyond those associated with the
central nervous system, including inflammatory and
immunological responses, cancer cell growth, migration
and apoptosis, and the response of the kidney to reper-
fusion injury [8, 13–15]. The UNC5B receptor is down-
regulated in bladder cancer tissues and is associated with
bladder cancer recurrence [10]. Therefore, we hypothe-
sized that UNC5B signaling plays a key role in the devel-
opment of bladder cancer. In this study, 5637 cells
stably transfected with UNC5B (5637-U) exhibited a
reduction in growth and wound healing ability compared
with control 5637 cells. Consistent with these findings,
UNC5B expression is enhanced in the non-aggressive
bladder cancer cell lines BIU-87, and cell migration is
decreased in BIU-87 cells overexpressing UNC5B [16].
The 5637-U cells grew at a slower rate, and tumors in
nude mice derived from 5637-U cells were smaller than
tumors derived from 5637 cells. Taken together, these
data show that UNC5B may suppress the progression
of bladder cancer. In addition, UNC5B overexpression
induced cell cycle arrest at the G2/M phase andas-
sembled more fluorescent spots in cytoplasm as the
arrow pointed, thereby decreasing the proliferation and
migration of 5637-U cells. Western blot analysis
suggested that cyclin D1 expression was increased in
5637-U cells whereas cyclin B1 and cyclin E expression
were unaffected, indicating that UNC5B may influence
the proliferaton of bladder cancer cells by regulating
the expression of proteins associated with cell cycle
progression from G2/M phase. Moreover, hepatic
metastases were identified in 2 nude mice injected with
5637 cells, whereas no metastases were observed in
nude mice injected with 5637-U cells. Bruno Larrivée
et al. demonstrated that UNC5B activation reduced
angiogenesis [11], indicating that UNC5B overexpres-
sion may be a critical prognostic factor in bladder
cancer metastasis. In summary, UNC5B is a potential
tumor suppressor in bladder cancer; however, the pre-
cise mechanism by which UNC5B influences bladder
cancer progression remains unclear and merits further
investigation.
Fig. 5 Tumors derived from UNC5B-overexpressing cells grew at a slower rate and were smaller in volume than tumors derived from 5637 cells.
a, b The sizes of the tumors on the backs of the mice were recorded 5, 9, 15, 19 and 21…days after the injection of tumor cells. Tumors derived
from 5637 cells grew at a faster rate and were larger in size than tumors derived from 5637-U cells on all days evaluated. c Representative images
of the nude mice used in the tumor transplant experiments
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Conclusion
Our results suggest that UNC5B overexpression inhibits
the proliferation and migration of bladder cancer cells
by inducing cell cycle arrest at G2/M phase.
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